NCT03816267

Brief Summary

Asthma is a problem that affects many children and affects their physical health in addition to having a social and financial burden on individuals, families and healthcare systems. In our pediatric emergency department, nebulizers are still used for the management of asthma and, with the poor resources of families, they have no option of treatment at home. In this study, the investigators will compare the effectiveness of treatment through nebulizer versus metered dose inhaler and spacer in children with an acute asthmatic attack seeking medical care at the Pediatric Emergency Department of Suez Canal University Hospital.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started May 2018

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 15, 2018

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 22, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 25, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 15, 2019

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2019

Completed
Last Updated

April 4, 2019

Status Verified

April 1, 2019

Enrollment Period

10 months

First QC Date

January 22, 2019

Last Update Submit

April 2, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical improvement

    Clinical respiratory score change (see Study Protocol for details)

    1 hour

Secondary Outcomes (2)

  • Rate of Hospitalization

    4 hours

  • Patient satisfaction

    1 hour

Study Arms (2)

Nebulizer

ACTIVE COMPARATOR

Containing salbutamol

Device: NebulizerDrug: Salbutamol

Metered Dose Inhaler and spacer

EXPERIMENTAL

Containing Salbutamol

Drug: SalbutamolDevice: Metered dose inhaler and spacer

Interventions

NebulizerDEVICE

Nebulization via mask

Nebulizer

Delivery of appropriate dose according to weight

Also known as: Albuterol, Ventolin
Metered Dose Inhaler and spacerNebulizer

Medication will be delivered through inhaler and spacer

Also known as: MDI
Metered Dose Inhaler and spacer

Eligibility Criteria

Age2 Years - 14 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children ranging from 2 - 14 years old.
  • Both genders will be included.
  • Patients with an acute exacerbation of asthma.

You may not qualify if:

  • Patients with arrhythmia and cardiac diseases.
  • Patients with thyroid diseases.
  • Patients with bronchiolitis, pneumonia. Patients with status asthmaticus requiring immediate pediatric intensive care unit hospitalization.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suez Canal University Hospital

Ismailia, 11411, Egypt

Location

Related Publications (1)

  • Rubilar L, Castro-Rodriguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol. 2000 Apr;29(4):264-9. doi: 10.1002/(sici)1099-0496(200004)29:43.0.co;2-s.

    PMID: 10738013BACKGROUND

MeSH Terms

Conditions

Asthma

Interventions

Nebulizers and VaporizersAlbuterolMetered Dose Inhalers

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Intervention Hierarchy (Ancestors)

Equipment and SuppliesEthanolaminesAmino AlcoholsAlcoholsOrganic ChemicalsAminesPhenethylaminesEthylamines

Study Officials

  • Alaa Zeitoun, Prof

    Suez Canal University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Pediatrics

Study Record Dates

First Submitted

January 22, 2019

First Posted

January 25, 2019

Study Start

May 15, 2018

Primary Completion

March 15, 2019

Study Completion

March 31, 2019

Last Updated

April 4, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations